Improving acute lymphoblastic leukemia diagnosis through CBAM-enhanced VGG19 deep learning.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
This study presents a deep learning framework with attention mechanisms for automated detection and subtyping of ALL from microscopic bone marrow images, including healthy samples.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Although the results are promising, the lack of external validation and the small dataset size limit clinical applicability. Therefore, this framework is a research prototype intended to serve as a basis for future large-scale, multi-center studies.
Acute Lymphoblastic Leukemia (ALL) is an aggressive blood cancer that requires rapid and accurate diagnosis.
APA
Rahman SIU, Abbas N, et al. (2026). Improving acute lymphoblastic leukemia diagnosis through CBAM-enhanced VGG19 deep learning.. Scientific reports, 16(1). https://doi.org/10.1038/s41598-026-40184-4
MLA
Rahman SIU, et al.. "Improving acute lymphoblastic leukemia diagnosis through CBAM-enhanced VGG19 deep learning.." Scientific reports, vol. 16, no. 1, 2026.
PMID
41741572 ↗
Abstract 한글 요약
Acute Lymphoblastic Leukemia (ALL) is an aggressive blood cancer that requires rapid and accurate diagnosis. Manual review of blood and bone marrow smears is time-consuming and observer-dependent, underscoring the need for automated methods. This study presents a deep learning framework with attention mechanisms for automated detection and subtyping of ALL from microscopic bone marrow images, including healthy samples. The model combines a Convolutional Block Attention Module (CBAM) with a VGG19 backbone, forming a hybrid CBAM-VGG19 network that hierarchically enhances key morphological features across spatial and channel dimensions. Incorporating CBAM into VGG19 improves feature extraction, accelerates learning, and boosts classification accuracy, particularly for visually similar leukemia subtypes. The model's performance was validated using k-fold cross-validation, achieving 98.73% classification accuracy, surpassing DenseNet121, InceptionV3, MobileNetV2, and the original VGG19. Further analyses examined the effects of image resolution, hyperparameter optimization, Bayesian tuning, and CBAM layer placement, all of which improved convergence and robustness while reducing overfitting. Although the results are promising, the lack of external validation and the small dataset size limit clinical applicability. Therefore, this framework is a research prototype intended to serve as a basis for future large-scale, multi-center studies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.